These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30175519)

  • 21. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus.
    Segarra-Medrano A; Jatem-Escalante E; Carnicer-Cáceres C; Agraz-Pamplona I; Salcedo MT; Valtierra N; Ostos-Roldán E; Arredondo KV; Jaramillo J
    Nefrologia; 2014; 34(4):491-7. PubMed ID: 25036063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary membranous nephropathy in adolescence: A prospective study.
    Kumar V; Varma AK; Nada R; Ghosh R; Suri D; Gupta A; Kumar V; Rathi M; Kohli H; Jha V; Gupta K; Ramachandran R
    Nephrology (Carlton); 2017 Sep; 22(9):678-683. PubMed ID: 27334445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy.
    Qin HZ; Zhang MC; Le WB; Ren Q; Chen DC; Zeng CH; Liu L; Zuo K; Xu F; Liu ZH
    J Am Soc Nephrol; 2016 Oct; 27(10):3195-3203. PubMed ID: 26989120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.
    Zhang Q; Liu X; Zhang Z; Wu M; Huang B; Zhang Y; Liu B; Qi Z; Shan W; Wang L; Hu Z; Sun Z
    Medicine (Baltimore); 2019 Nov; 98(45):e17658. PubMed ID: 31702617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.
    Bech AP; Hofstra JM; Brenchley PE; Wetzels JF
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1386-92. PubMed ID: 25035272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
    Oh YJ; Yang SH; Kim DK; Kang SW; Kim YS
    PLoS One; 2013; 8(4):e62151. PubMed ID: 23637987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compared staining of the phospholipase A2 receptor in the glomeruli of Chinese adults and children with idiopathic membranous nephropathy.
    Zhang D; Wu Y; Zhang C; Zhang W; Zou J; Jiang G
    Pathol Res Pract; 2019 May; 215(5):952-956. PubMed ID: 30765126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.
    Xu NX; Xie QH; Sun ZX; Wang J; Li Y; Wang L; Liu SJ; Xue J; Hao CM
    Chin Med J (Engl); 2017 Apr; 130(8):892-898. PubMed ID: 28397717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
    Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
    Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
    Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy.
    Li C; Li H; Wen YB; Li XM; Li XW
    BMC Nephrol; 2018 Dec; 19(1):354. PubMed ID: 30541581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.
    Zhang QH; Wu M; Hu ZG; Liu XB; Huang B; Zhang Y; Liu B; Zhu YS; Wang L; Sun ZX
    Biomed Res Int; 2020; 2020():1693710. PubMed ID: 32461964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA; McRae JL; Dwyer KM
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membranous nephropathy: integrating basic science into improved clinical management.
    Cattran DC; Brenchley PE
    Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. M-type phospholipase A
    Kanda S; Horita S; Yanagihara T; Shimizu A; Hattori M
    Pediatr Nephrol; 2017 Apr; 32(4):713-717. PubMed ID: 27921164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
    Barrett C; Willcocks LC; Jones RB; Tarzi RM; Henderson RB; Cai G; Gisbert SI; Belson AS; Savage CO
    Nephrol Dial Transplant; 2020 Apr; 35(4):599-606. PubMed ID: 31243451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.